Trial Profile
A Phase I/II Trial Of MGI114 For Treatment Of Patients With Recurrent Malignant Gliomas
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Irofulven (Primary)
- Indications Astrocytoma; Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2007 New trial record.